GlassScriptPhysician profile
Brian Subach
NPI 1598733776
$41,304.20
in general payments reported to CMS, 2019-2025
41 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,820 · 2020: $8,732 · 2021: $6,734 · 2022: $14K · 2023: $8,671 · 2024: $862.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,450 · Food and Beverage: $2,210 · Travel and Lodging: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,450.00 |
| Food and Beverage | $2,209.59 |
| Travel and Lodging | $873.78 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $22,989.00 | 2021-2024 | Graftonand Grafton Plusdemineralized Bone Matrix (Dbm), Intellis Adaptivestim, Synchromedii |
| Medtronic USA, INC. | $10,129.67 | 2019-2020 | |
| Intelivation Technologies, LLC | $4,500.00 | 2021-2022 | |
| Boston Scientific Corporation | $759.68 | 2021-2023 | Wavewriter Alpha Prime 16, Spectra Wavewriter, Infinion 16 |
| Si-Bone, INC. | $406.69 | 2021-2024 | |
| Collegium Pharmaceutical, INC. | $386.26 | 2021-2024 | Belbuca, Xtampza |
| Mml US, INC. | $286.83 | 2023-2024 | Reactiv8 |
| Abbott Laboratories | $260.01 | 2020-2024 | Proclaim |
| Nevro Corp. | $205.21 | 2019-2021 | |
| Relievant Medsystems, INC. | $123.60 | 2022-2023 | Intracept |
| Almatica Pharma LLC | $119.95 | 2021-2022 | |
| Providence Medical Technology, INC. | $90.89 | 2021 | |
| Redhill Biopharma INC. | $81.70 | 2021-2022 | |
| Depuy Synthes Sales INC. | $66.58 | 2019 | |
| Fidia Pharma USA INC. | $60.04 | 2022-2023 | Hymovis |
Show all 41 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Subach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.